Tap either name to swap in any company, coin or metal, and everything below updates as you pick.
One Inhibikase Therapeutics share would cost
$71,666.14
$10.0T spread across 139.5M Inhibikase Therapeutics shares.
This holds the unit count fixed and moves only the valuation, which is what makes it a clean illustration of relative size. It is not a forecast, a target, or a claim that either outcome is possible: assets of very different kinds rarely end up worth the same.